Rhythm Pharmaceuticals IncNASDAQ:RYTM
- LAST PRICE41.0100
- TODAY'S CHANGE (%)1.0400 (2.6020%)
- Bid / Lots37.0000/ 8
- Ask / Lots41.2800/ 1
- Open / Previous Close39.3100 / 39.9700
- Day Range
- 52 Week Range
- Volume402,629
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RYTM |
|---|---|---|
| 09:32 ET | 5110 | 39.24 |
| 09:34 ET | 1303 | 39.25 |
| 09:36 ET | 100 | 39.32 |
| 09:39 ET | 100 | 39.06 |
| 09:41 ET | 842 | 39.2 |
| 09:43 ET | 1330 | 39.52 |
| 09:45 ET | 1200 | 39.46 |
| 09:48 ET | 500 | 39.56 |
| 09:50 ET | 100 | 39.545 |
| 09:52 ET | 245 | 39.455 |
| 09:54 ET | 160 | 39.395 |
| 09:57 ET | 100 | 39.385 |
| 10:01 ET | 7929 | 39.42 |
| 10:03 ET | 2451 | 39.05 |
| 10:06 ET | 800 | 39 |
| 10:08 ET | 1820 | 38.96 |
| 10:10 ET | 2308 | 39.005 |
| 10:12 ET | 453 | 38.9 |
| 10:14 ET | 540 | 39.16 |
| 10:15 ET | 448 | 39.2 |
| 10:17 ET | 600 | 39.17 |
| 10:19 ET | 100 | 39.225 |
| 10:21 ET | 400 | 39.28 |
| 10:24 ET | 900 | 39.205 |
| 10:26 ET | 100 | 39.18 |
| 10:28 ET | 1000 | 39.345 |
| 10:30 ET | 100 | 39.27 |
| 10:32 ET | 100 | 39.2001 |
| 10:33 ET | 1127 | 39.505 |
| 10:37 ET | 300 | 39.6 |
| 10:50 ET | 1529 | 39.91 |
| 10:51 ET | 495 | 39.91 |
| 10:53 ET | 558 | 40.015 |
| 10:55 ET | 200 | 40.02 |
| 10:57 ET | 200 | 40.14 |
| 11:00 ET | 100 | 40.145 |
| 11:06 ET | 200 | 40.13 |
| 11:08 ET | 385 | 40.18 |
| 11:09 ET | 100 | 40.1876 |
| 11:11 ET | 300 | 40.25 |
| 11:18 ET | 600 | 40.27 |
| 11:20 ET | 500 | 40.32 |
| 11:22 ET | 100 | 40.38 |
| 11:24 ET | 100 | 40.35 |
| 11:27 ET | 4125 | 40.25 |
| 11:36 ET | 300 | 40.31 |
| 11:38 ET | 200 | 40.31 |
| 11:40 ET | 200 | 40.275 |
| 11:45 ET | 200 | 40.235 |
| 11:47 ET | 500 | 40.29 |
| 11:56 ET | 900 | 40.36 |
| 11:58 ET | 2600 | 40.59 |
| 12:02 ET | 138 | 40.59 |
| 12:03 ET | 128 | 40.58 |
| 12:05 ET | 100 | 40.58 |
| 12:07 ET | 200 | 40.62 |
| 12:09 ET | 903 | 40.45 |
| 12:12 ET | 2578 | 40.555 |
| 12:14 ET | 125 | 40.495 |
| 12:18 ET | 300 | 40.61 |
| 12:20 ET | 419 | 40.69 |
| 12:21 ET | 500 | 40.82 |
| 12:23 ET | 200 | 40.75 |
| 12:25 ET | 100 | 40.77 |
| 12:27 ET | 423 | 40.7 |
| 12:30 ET | 300 | 40.66 |
| 12:32 ET | 200 | 40.665 |
| 12:34 ET | 3162 | 40.685 |
| 12:36 ET | 100 | 40.69 |
| 12:38 ET | 200 | 40.69 |
| 12:39 ET | 1945 | 40.775 |
| 12:41 ET | 533 | 40.78 |
| 12:43 ET | 1200 | 40.59 |
| 12:48 ET | 100 | 40.47 |
| 12:50 ET | 100 | 40.38 |
| 12:52 ET | 300 | 40.27 |
| 12:54 ET | 100 | 40.25 |
| 12:56 ET | 840 | 40.325 |
| 12:57 ET | 400 | 40.38 |
| 01:06 ET | 300 | 40.2 |
| 01:08 ET | 200 | 40.2 |
| 01:10 ET | 200 | 40.15 |
| 01:12 ET | 14500 | 40.23 |
| 01:14 ET | 100 | 40.17 |
| 01:19 ET | 1100 | 40.22 |
| 01:21 ET | 100 | 40.225 |
| 01:24 ET | 700 | 40.26 |
| 01:26 ET | 1000 | 40.12 |
| 01:30 ET | 200 | 40.04 |
| 01:32 ET | 200 | 39.93 |
| 01:33 ET | 100 | 39.93 |
| 01:35 ET | 700 | 39.77 |
| 01:37 ET | 300 | 39.72 |
| 01:39 ET | 200 | 39.805 |
| 01:42 ET | 400 | 39.865 |
| 01:46 ET | 1006 | 39.925 |
| 01:48 ET | 587 | 39.9178 |
| 01:50 ET | 100 | 39.83 |
| 01:51 ET | 100 | 39.75 |
| 01:55 ET | 100 | 39.74 |
| 02:00 ET | 100 | 39.71 |
| 02:02 ET | 1100 | 39.83 |
| 02:06 ET | 300 | 39.8 |
| 02:08 ET | 186 | 39.8 |
| 02:09 ET | 400 | 39.73 |
| 02:11 ET | 500 | 39.66 |
| 02:13 ET | 1494 | 39.475 |
| 02:15 ET | 400 | 39.47 |
| 02:18 ET | 400 | 39.35 |
| 02:20 ET | 1730 | 39.435 |
| 02:22 ET | 337 | 39.495 |
| 02:24 ET | 879 | 39.64 |
| 02:26 ET | 100 | 39.63 |
| 02:27 ET | 400 | 39.5 |
| 02:29 ET | 100 | 39.46 |
| 02:31 ET | 100 | 39.51 |
| 02:36 ET | 400 | 39.56 |
| 02:38 ET | 300 | 39.62 |
| 02:40 ET | 300 | 39.68 |
| 02:42 ET | 900 | 39.82 |
| 02:44 ET | 1000 | 39.8925 |
| 02:45 ET | 200 | 39.92 |
| 02:47 ET | 500 | 39.98 |
| 02:49 ET | 300 | 40.02 |
| 02:51 ET | 800 | 40.15 |
| 02:54 ET | 300 | 40.115 |
| 02:56 ET | 100 | 40.14 |
| 02:58 ET | 100 | 40.14 |
| 03:00 ET | 500 | 40.16 |
| 03:02 ET | 1300 | 40.09 |
| 03:03 ET | 300 | 40.06 |
| 03:05 ET | 400 | 39.98 |
| 03:07 ET | 100 | 39.92 |
| 03:09 ET | 200 | 39.84 |
| 03:12 ET | 100 | 39.84 |
| 03:14 ET | 400 | 39.88 |
| 03:16 ET | 1300 | 40.13 |
| 03:18 ET | 400 | 40.03 |
| 03:20 ET | 600 | 39.95 |
| 03:21 ET | 300 | 40 |
| 03:25 ET | 100 | 39.96 |
| 03:27 ET | 100 | 39.97 |
| 03:30 ET | 340 | 40.06 |
| 03:32 ET | 500 | 40.1 |
| 03:34 ET | 800 | 40.1925 |
| 03:36 ET | 200 | 40.3 |
| 03:38 ET | 200 | 40.32 |
| 03:41 ET | 2023 | 40.4 |
| 03:43 ET | 100 | 40.36 |
| 03:45 ET | 200 | 40.37 |
| 03:48 ET | 4196 | 40.385 |
| 03:50 ET | 4705 | 40.54 |
| 03:52 ET | 1898 | 40.455 |
| 03:54 ET | 2302 | 40.66 |
| 03:56 ET | 8994 | 40.795 |
| 03:57 ET | 6868 | 40.865 |
| 03:59 ET | 130912 | 41.01 |
Jun 3, 2024
Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024, from 4:02PM ET on Monday Jun 03, 2024 by Dow Jones
4:02PM ET on Monday Jun 03, 2024 by Dow JonesRhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference, from 8:02AM ET on Monday Jun 03, 2024 by Dow Jones
8:02AM ET on Monday Jun 03, 2024 by Dow Jones
May 22, 2024
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for IMCIVREE(R) (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome, from 4:00AM ET on Wednesday May 22, 2024 by Dow Jones
4:00AM ET on Wednesday May 22, 2024 by Dow JonesRhythm Pharmaceuticals Receives Positive Recommendation from NICE for IMCIVREE(R) (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome, from 4:00AM ET on Wednesday May 22, 2024 by Dow Jones
4:00AM ET on Wednesday May 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rhythm Pharmaceuticals Inc | 2.4B | -8.9x | --- |
Kymera Therapeutics Inc | 2.0B | -13.7x | --- |
Intellia Therapeutics Inc | 2.2B | -4.3x | --- |
Recursion Pharmaceuticals Inc | 2.1B | -5.3x | --- |
Avidity Biosciences Inc | 2.5B | -9.2x | --- |
Arvinas Inc | 1.9B | -4.5x | --- |
Company Information
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE, as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. IMCIVREE is approved by the Food and Drug Administration (FDA) for chronic weight management in adult and pediatric patients six years of age and older with monogenic or syndromic obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1) or leptin receptor (LEPR) deficiency as determined by an FDA-approved test demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS); or Bardet-Biedl syndrome (BBS). It is evaluating setmelanotide in Phase II and III trials for the treatment of obesity due to variants in one of numerous genes associated with the MC4R pathway.
Contact Information
- Headquarters
- 222 Berkeley Street, 12th Floor BostonBOSTON, MA, United States 02116
- Phone
- 857-264-4280
- Fax
- 857-264-4299
Executives
- Chairman of the Board, President, Chief Executive Officer
- David Meeker
- Chief Financial Officer, Treasurer
- Hunter Smith
- Chief Human Resource Officer
- Pamela Cramer
- Executive Vice President, Head of North America
- Jennifer Lee
- Executive Vice President, Head of International
- Yann Mazabraud
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $91.9M |
Shares Outstanding | 61.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-4.62 |
Book Value | $2.86 |
P/E Ratio | -8.9x |
Price/Sales (TTM) | 26.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -295.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
